|
Oct 11
|
Vivoryon Therapeutics N.V. Announces Late-breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024
|
|
Sep 26
|
This Vivoryon Therapeutics Insider Increased Their Holding By 143% Last Year
|
|
Jun 21
|
Vivoryon Therapeutics N.V. Reports Outcome of 2024 Annual General Meeting
|
|
May 15
|
Vivoryon Therapeutics N.V. to Report Q1 2024 Financial Results and Operational Progress on May 23, 2024
|
|
Dec 6
|
Vivoryon Therapeutics N.V. Reports Third Quarter 2023 Financial Results and Highlights Operational Progress
|
|
Dec 3
|
When Will Vivoryon Therapeutics N.V. (AMS:VVY) Turn A Profit?
|
|
Nov 28
|
Vivoryon Therapeutics N.V. to Report Q3 2023 Financial Results and Operational Progress on December 6, 2023
|
|
Sep 28
|
Is Vivoryon Therapeutics (AMS:VVY) In A Good Position To Deliver On Growth Plans?
|